OR52W1

Across TCGA pan-cancer cohorts, OR52W1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated OR52W1 data layer compared with 16 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher OR52W1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR52W1 expression acts as an unfavorable survival marker.

CESC, ESCA, and BLCA are the cancer types where OR52W1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	All	0.151	0.798	<.001	12	view →
ESCA	DFS	Median	All	0.052	0.533	<.001	12	view →
BLCA	DFS	Median	All	0.182	0.510	.044	6	view →
LUAD	OS	Median	All	0.254	0.697	.020	6	view →
SKCM	OS	Median	All	0.680	0.876	.029	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR52W1–CESC (OS)

Open the CESC breakdown →